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Purpose: The aim of the present study was to deﬁne the atrial electrical substrate in patients with
paroxysmal atrial ﬁbrillation (AF) occurring in the absence of overt structural heart disease and to assess
if electrophysiological parameters could predict AF recurrence after radiofrequency ablation in this
population.
Methods and results: 45 consecutive patients (39 male, age 59 ± 10 years) with paroxysmal AF and
without overt structural heart disease, referred for radiofrequency catheter ablation, were prospectively
enrolled. A cohort of 12 age-matched patients without a history of AF, served as a control group. Atrial
electrical substrate was assessed by P-wave signal-averaging, intracardiac conduction delays and re-
fractory periods. Total P wave duration during signal-averaging was longer in patients with paroxysmal
AF than in controls (140 ± 19 ms vs 123 ± 13 ms, p ¼ 0.004). Patients with paroxysmal AF showed an
increase in right intra-atrial (40.2 ± 11.3 ms vs 31.7 ± 11.8 ms, p ¼ 0.02) and inter-atrial conduction delays
(87.93 ± 22.0 ms vs 65.3 ± 15.6 ms, p ¼ 0.001) in sinus rhythm. Refractory periods in the right atrium
were longer in patients with paroxysmal AF (265 ± 44 ms vs 222 ± 32 ms, p ¼ 0.002). After ablation, 22
patients had AF recurrence but showed no differences in electrophysiological parameters compared to
patients without recurrence.
Conclusion: Electrophysiological abnormalities are present in patients with paroxysmal AF without overt
structural heart disease. Neither signal-averaged P-wave duration nor intracardiac atrial electrophysi-
ology could predict arrhythmia recurrence after pulmonary vein isolation.
Copyright © 2016, Indian Heart Rhythm Society. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Atrial ﬁbrillation (AF) is the most common sustained arrhythmia
encountered in clinical practice. Although this arrhythmia is pri-
marily seen in the elderly or in patients with heart disease, it is not
exceptional to diagnose AF in patients without any overt structural
heart disease or in relatively young patients [1]. This observation
has lead Evans and Swann in 1954 to introduce the term “lone”
atrial ﬁbrillation, which has been used for decades by clinicians [2].
However, it has been recommended recently that the use of termsCH-1217, Meyrin, Geneva,
(M. Zimmermann).
Rhythm Society.
ociety. Production and hosting bysuch as “idiopathic AF” or “lone AF” be avoided, because there has
been a huge progress in the understanding of the pathophysiology
of AF in the last 20 years; many causes of AF have been highlighted
(obesity, sleep-apnea-syndrome, alcohol, vagal or adrenergic in-
ﬂuences, excessive sporting activities, family history, genetics etc
[3,4]), and abnormal electrical and anatomical substrates have been
identiﬁed [5e9], including occult myocardial diseases as proven by
atrial or ventricular biopsies [10,11].
In the present study we used signal-averaged P-wave analysis
and intracardiac recordings to deﬁne the atrial electrical substrate
of patients with paroxysmal AF occurring in the absence of overt
structural heart disease and submitted to pulmonary vein isolation.
We also tried to deﬁne if electrophysiological parameters could be
predictive for arrhythmia recurrences after ablation in these
patients.Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
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2.1. Patients
After informed consent, 45 consecutive patients (39 male, 6
female, mean age 59 ± 10 years) with paroxysmal AF referred for de
novo radiofrequency catheter ablation (pulmonary vein isolation)
were prospectively enrolled. Patients were considered eligible for
catheter ablation if they had documented symptomatic AF, at least
one failed antiarrhythmic drug and no history of coronary artery
disease, heart failure, diabetes or pulmonary disease, with a normal
physical examination, resting 12-lead ECG, transthoracic and
transoesophageal echocardiogram (mild mitral regurgitation and
mild atrial dilatation were not excluded). Patients were treated
either with uninterrupted acenocoumarol (target INR of 2.0e3.0) or
non-vitamin K oral anticoagulants (interrupted the day before the
procedure). All patients underwent transoesophageal echocardi-
ography immediately before the ablation procedure to exclude left
atrial thrombi. All antiarrhythmic drugs were interrupted since at
least 5 half-lives before ablation. A control group of 12 aged-
matched without any history of AF, structural heart disease or hy-
pertension and submitted to an electrophysiological study for
syncope or supraventricular tachycardia was included in the study
for comparison (Table 1).2.2. Radiofrequency (RF) procedure
The procedure was performed in a fasting state under light
sedation with midazolam and/or fentanyl. Only the right femoral
vein was used for insertion of catheters, and in the absence of a
patent foramen ovale a single transseptal puncture was performed
using the Brockenbrough technique and a long sheath (SL0, St Jude
Medical, St Paul, MN, USA). For the conventional point-by-point
approach (n ¼ 14), 3 catheters were inserted: one duodecapolar
lasso catheter for pulmonary vein (PV) recording (introduced
through the SL0 long sheath and positioned at the ostium of each
PV sequentially), one 4-mm irrigated-tip ablation catheter for
segmental isolation, and one decapolar (2 mm spacing) steerable
catheter in the distal coronary sinus. For circular irrigated radio-
frequency ablation (nMARQ, Biosense Webster, n ¼ 31), only 2
catheters were inserted: one catheter for mapping and ablation in
the left atrium (nMARQ catheter) and one decapolar (2 mm
spacing) steerable catheter in the distal coronary sinus. TheTable 1
Clinical and electrophysiological characteristics in the control group and in patients w
Control group
n ¼ 12
Age (years) 58.6 ± 12.3
Left atrial diameter (cm) 33.8 ± 3.4
Left atrial surface (cm2) 15.8 ± 1.5
Left ventricular ejection fraction (%) 70.4 ± 4.0
P wave duration (ms) 122.8 ± 12.8
RMS 20 (mV) 3.50 ± 2.61
RMS 30 (mV) 4.75 ± 3.04
RMS 40 (mV) 5.25 ± 3.16
P wave integral (mVs) 525 ± 161
HRA-HBE (ms) 31.7 ± 11.8
HRA-pCS during sinus rhythm (ms) 54.3 ± 14.9
HRA-pCS during pacing 600 ms (ms) 76.2 ± 13.8
HRA-dCS during sinus rhythm (ms) 65.3 ± 15.6
HRA-dCS during pacing 600 ms (ms) 92.8 ± 16.6
Right atrial ERP (ms) 221.7 ± 31.9
Left atrial ERP (ms) 257.5 ± 33.9
dCS ¼ distal coronary sinus; ERP ¼ effective refractory period; FRP ¼ functional refra
right atrium; pCS ¼ proximal coronary sinus; ms ¼ milliseconds; RMS ¼ root meantechnique has been described in detail previously [12]. After
transseptal puncture, a bolus of intravenous heparin was admin-
istered to aim for an ACT of 250e350 s and 3D electro-anatomical
mapping using the CARTO3 system (Biosense Webster) was per-
formed in all cases. With the point-by-point approach, ostial
segmental isolation of all 4 PVs was performed using the ablation
catheter under the guidance of the circumferential mapping cath-
eter in the PV (maximum power 30e35 Watts; maximal temper-
ature 48; duration of the RF application 60 s). For circular irrigated
nMARQ RF ablation, maximal power was 15 Watts and RF current
was applied during 40 s at each site. The endpoint of RF application
was complete PV isolation, demonstrated by the absence of PV
potentials during sinus rhythm or coronary sinus pacing. Recon-
ﬁrmation of PV isolation was performed 30 min after ablation for
each PV. Patients were followed with continuous ECG monitoring
for 24 h and were discharged from the hospital the day after the
procedure. Patients were prospectively followed for up to 18
months or until recurrences occurred. Recurrences were deﬁned as
documented AF (duration > 30 s) occurring after a blanking period
of 2 months after the ablation procedure. To conﬁrm AF recurrence,
serial 12-lead ECG recordings were obtained as well as at least one
24-h Holter ECG or one 7-days loop recording at 3e6 months post-
procedure. Anticoagulation was maintained for 3 months in the
absence of recurrence and longer in the presence of recurrences.2.3. Intracardiac recordings
Intra-atrial conduction (right atrial conduction) was evaluated
by measuring the interval between the atrial component in the
high right atrium (HRA) and the atrial component recorded with
the His bundle electrode(HBE) or with the proximal pole of the
decapolar catheter-electrode positioned inside the coronary sinus
(pCS), during sinus rhythm and during right atrial pacing (at
600 ms cycle length). Inter-atrial conduction was evaluated by
measuring the interval between the atrial component in the high
right atrium (HRA) and the atrial component recorded with the
distal pole of the decapolar catheter-electrode positioned inside the
coronary sinus (dCS), during sinus rhythm and during right atrial
pacing (at 600 ms cycle length). The effective refractory period
(ERP) of the right and the left atrium were determined by extra-
stimulation during continuous pacing at 600 ms, at twice the dia-




58.8 ± 9.9 0.32
38.9 ± 4.3 0.0003*
19.9 ± 2.8 <0.0001*
67.1 ± 3.7 0.008*
140.3 ± 19.3 0.004*
3.95 ± 2.64 0.59
4.68 ± 2.77 0.94
5.24 ± 2.74 0.99
646 ± 260 0.13
40.2 ± 11.3 0.02*
63.9 ± 17.4 0.08
88.9 ± 18.9 0.03*
87.9 ± 22.0 0.001*
118.4 ± 22.2 0.0005*
265.0 ± 43.7 0.002*
271.8 ± 26.9 0.12
ctory period; HBE ¼ atrial electrogram on the His bundle electrode; HRA ¼ high
square; mV ¼ microvolt. * ¼ statistically signiﬁcant.
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A P-wave signal averaged recording was obtained within 1 h
after the ablation procedure in all patients using the Phi-Res anal-
ysis module from Marquette Medical system (GE Healthcare,
Waukesha, WI, USA). This recording was obtained after the pro-
cedure for homogeneity purposes, as some patients were in AF
before the procedure. The system has a sampling frequency of
1000 Hz. The software provides ﬁltering and automatic delineation
of the averaged P-wave. Automatic measurements include total
unﬁltered and ﬁltered P-wave duration (FPD), P-wave integral, and
Root Mean Squared (RMS) voltages of the terminal 20, 30, and
40 ms. Electrocardiographic data were obtained using three
orthogonal bipolar leads (X, Y, Z) and the three leads were com-
bined into a vector magnitude VM (VM ¼ √(X2þY2þZ2)). The P-
wave was used as a trigger for the averaging process. Qualiﬁed P-
waves were correlated with a P-wave template (generated on the
ﬁrst 10 beats), and only P-waves with a correlation coefﬁcient
>0.95 were taken into account for the averaging process, for
ﬁltering (Fast Fourier Transform ﬁlters; high-pass ﬁlter of 40 Hz,
low-pass ﬁlter of 250 Hz) and for analysis. The endpoint for the
averaging process was predetermined (250 beats) and only re-
cordings with a residual noise level < 0.5 mV were used. All tracings
were veriﬁed by two independent observers and automatic mea-
surements were corrected according to visual delineation of the
beginning and of the end of the P-wave.
2.5. Statistical analysis
Data are expressed as mean ± standard deviation. after testing
for normality of distribution, differences in continuous variables
were performed using Student's unpaired t-test. Differences in
categorical datawere performed using Chi-square or Fischer's exact
test. A p value of less than 0.05 was considered signiﬁcant. The
correlation between P-wave duration and parameters of intra or
inter-atrial conduction was assessed using Pearson's correlation
coefﬁcient.
3. Results
The clinical and electrophysiological characteristics of the pa-
tients are summarized in Table 1. Ten patients had mild and well-
controlled hypertension without any sign of left ventricular hy-
pertrophy or diastolic dysfunction on echocardiography.
Total P wave duration measured by signal-averaging was
signiﬁcantly longer in patients with paroxysmal AF than in controls,
but no other signal-averaged parameters were different between
the 2 groups. Intracavitary measurements showed a signiﬁcant
increase in intra- and inter-atrial conduction times in paroxysmal
AF patients compared to controls. Refractory periods measured in
the right atrium were longer in patients with paroxysmal AF, but
there was no signiﬁcant difference between the 2 groups for the
refractory periods measured in the left atrium. A weak but signif-
icant correlation was observed between age and P-wave duration
during signal-averaging (r2¼ 0.16, p¼ 0.006), between age and left
atrial size (r2 ¼ 0.15, p ¼ 0.006), between P-wave duration and left
atrial size (r2 ¼ 0.30, p < 0.0001), between P-wave duration and
intra-atrial conduction time (r2 ¼ 0.23, p ¼ 0.0008), or inter-atrial
conduction time (r2 ¼ 0.24, p ¼ 0.0005), but only during pacing.
No correlation was found between P-wave duration and values of
refractory periods.
Analysis was also performed for the subgroup of so-called “lone”
AF (exclusion of patients > 60 years of age and/or patients with
hypertension even if well controlled). Results were similar as for
the analysis if the entire AF group (Table 2).Among the 45 patients with paroxysmal AF, 22 had AF recur-
rence after RF ablation, 5 (36%) in the point-by-point ablation
group, and 17 (55%) in the nMARQ ablation group. Compared to
patients who had no AF recurrence during a mean FU of 11.9 ± 4.6
months, patients with recurrences showed no differences in terms
of clinical data, signal-averaged parameters or intracavitary re-
cordings (Table 3). Among the 22 patients who had recurrences
after the ﬁrst ablation, 12 underwent a second ablation procedure,
and in all cases focal pulmonary vein reconductionwas observed as
the mechanism for recurrence.
4. Discussion
The main results of the present study are:
a) Patients with paroxysmal AF without overt structural heart
disease have electrical remodeling. Compared to age-matched
control individuals, these patients have larger atria, longer P-
wave durations measured by signal-averaging, impaired intra-
and inter-atrial conduction, and longer refractory periods in the
right atrium. The same ﬁndings applywhen analysis is restricted
to “lone” paroxysmal AF patients, suggesting that even in this
speciﬁc subgroup, some electrical abnormalities are present
making the term “lone” inadequate and obsolete. These results
are in agreement with previous studies showing signiﬁcant
modiﬁcations in P-wave morphology [8], altered atrial conduc-
tive properties [6,13e16], prolonged regional refractoriness [14],
increased atrial dispersion of refractoriness [17] and shortening
of atrial refractory periods [18], in patients with paroxysmal
“lone” AF. It has also been shown that these patients have evi-
dence of atrial ﬁbrosis on magnetic resonance imaging [19].
b) Total P-wave duration measured using signal-averaging, is corre-
lated with atrial size and with intra and inter-atrial conduction
times. It is established that the P-wave duration reﬂects inter- and
intra-atrial conduction time and a prolonged P-wave implies atrial
conduction delay, often not recognized on a standard electrocar-
diogram [20]. This electrical abnormality is generally associated
with subclinical structural abnormalities, such as ﬁbrosis and left
atrial enlargement [21]which causemechanical atrial dysfunction
[22]. This electro-anatomic remodeling is involved in the initiation
and perpetuation of AF [23,24], apparently even in patients with
no detectable structural heart disease.
c) None of the electrophysiological parameters measured in this
study (using P-wave signal-averaging or by intracavitary re-
cordings) was useful to predict AF recurrence after RF catheter
ablation. A few studies [25e28] have used the SAECG to study
the effect of RF catheter ablation on the P-wave and to predict
the risk of recurrences after ablation. The results of these studies
are conﬂicting. Some studies showed that is the technique was
useful to predict recurrences [25e27] whereas other data did
not [28], probably because of different study design, small
numbers of patients, various SAECGmethodologies and variable
deﬁnition of recurrences. The high recurrence rate in our study
was essentially due to use of the nMARQ catheter with low
power settings, which was probably a confounding factor with
reconnection of the pulmonary veins. The patients included in
the present study were part of a series of 50 patients ablated
with this circular multipolar ablation catheter in whom we re-
ported a recurrence rate of 54% after a follow-up of 15 ± 4
months [12].5. Limitations
The sample size is relatively small. The present results may not
Table 2






Age (years) 58.6 ± 12.3 51.5 ± 6.7 0.03*
Left atrial diameter (cm) 33.8 ± 3.4 37.5 ± 3.1 0.002*
Left atrial surface (cm2) 15.8 ± 1.5 19.1 ± 2.1 <0.0001*
Left ventricular ejection fraction (%) 70.4 ± 4.0 68.0 ± 3.3 0.06
P wave duration (ms) 122.8 ± 12.8 133.2 ± 15.4 0.053
RMS 20 (mV) 3.50 ± 2.61 4.34 ± 2.80 0.39
RMS 30 (mV) 4.75 ± 3.04 5.43 ± 2.79 0.50
RMS 40 (mV) 5.25 ± 3.16 6.01 ± 2.62 0.46
P wave integral (mVs) 525 ± 161 664 ± 236 0.07
HRA-HBE (ms) 31.7 ± 11.8 40.1 ± 12.4 0.06
HRA-pCS during sinus rhythm (ms) 54.3 ± 14.9 61.9 ± 19.1 0.23
HRA-pCS during pacing 600 ms (ms) 76.2 ± 13.8 81.7 ± 12.0 0.22
HRA-dCS during sinus rhythm (ms) 65.3 ± 15.6 85.1 ± 21.4 0.008*
HRA-dCS during pacing 600 ms (ms) 92.8 ± 16.6 110.9 ± 13.5 0.001*
Right atrial ERP (ms) 221.7 ± 31.9 253.7 ± 47.6 0.004*
Left atrial ERP (ms) 257.5 ± 33.9 271.7 ± 25.3 0.16
dCS¼ distal coronary sinus; ERP¼ effective refractory period; HBE¼ atrial electrogram on the His bundle electrode; HRA¼ high right atrium; pCS¼ proximal coronary
sinus; ms ¼ milliseconds; RMS ¼ root mean square; mV ¼ microvolt. * ¼ statistically signiﬁcant.
Table 3
Clinical and electrophysiological characteristics of patients with paroxysmal atrial ﬁbrillation (AF) in the absence of structural heart disease who had recurrences versus those






Age (years) 59.3 ± 10.4 58.3 ± 9.8 0.78
Left atrial diameter (cm) 39.5 ± 4.6 38.4 ± 4.1 0.56
Left atrial surface (cm2) 20.6 ± 3.0 19.4 ± 2.6 0.15
Left ventricular ejection fraction (%) 66.5 ± 4.0 67.7 ± 3.3 0.24
P wave duration (ms) 141.9 ± 21.3 138.7 ± 17.4 0.57
RMS 20 (mV) 4.36 ± 2.96 3.56 ± 2.29 0.31
RMS 30 (mV) 4.59 ± 2.64 4.78 ± 2.95 0.82
RMS 40 (mV) 5.18 ± 2.32 5.30 ± 3.15 0.88
P wave integral (mVs) 663 ± 262 630 ± 262 0.66
HRA-HBE (ms) 37.0 ± 8.2 43.1 ± 13.0 0.06
HRA-pCS during sinus rhythm (ms) 61.1 ± 15.9 66.7 ± 18.7 0.29
HRA-pCS during pacing 600 ms (ms) 91.0 ± 20.9 86.9 ± 16.9 0.47
HRA-dCS during sinus rhythm (ms) 86.9 ± 24.0 88.8 ± 20.4 0.77
HRA-dCS during pacing 600 ms (ms) 119.3 ± 25.2 117.5 ± 19.4 0.78
Right atrial ERP (ms) 263.9 ± 44.5 266.1 ± 43.9 0.86
Left atrial ERP (ms) 268.2 ± 32.2 275.2 ± 20.9 0.38
dCS¼ distal coronary sinus; ERP¼ effective refractory period; HBE¼ atrial electrogram on the His bundle electrode; HRA¼ high right atrium; pCS¼ proximal coronary sinus;
ms ¼ milliseconds; RMS ¼ root mean square; mV ¼ microvolt.
J.D. Arroja et al. / Indian Pacing and Electrophysiology Journal 16 (2016) 152e156 155be applicable to other methods of P-wave signal averaging. P-wave
signal averaged recording were performed after pulmonary vein
isolation, which may induced differences between the AF and
control groups. However, as we performed segmental ostial isola-
tion, with non-circumferential lesions and limited numbers of ap-
plications, this is unlikely to have led to atrial conduction delay. Our
results are only applicable to AF patients undergoing PV isolation
using the techniques described in this paper and may not be
applicable to patients undergoing wide circumferential ablation
(WACA), CFAE ablation or posterior left atrial isolation. Finally, the
control group was comprised of patients without detectable
structural heart disease, but who nevertheless had an indication for
an electrophysiological study or supra-ventricular arrhythmia
ablation, and therefore was not a “normal” population. However,
atrial abnormalities in these patients would have served to reduce
differences between the groups.6. Conclusion
Electrophysiological abnormalities are present in patients with
paroxysmal AF without any structural heart disease, probablyreﬂecting the presence of a primary atrial disease and/or the extent
of remodeling. P-wave signal-averaged parameters correlate with
left atrial size and intra- or inter-atrial conduction. Neither signal-
averaged P-wave duration nor intracardiac atrial electrophysiology
are useful to predict arrhythmia recurrence after an initially suc-
cessful pulmonary vein isolation using the ablation techniques
described in our series.
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